Efficacy of Pre-surgical Axitinib for Shrinkage of Inferior Vena Cava Thrombus in a Patient with Advanced Renal Cell Carcinoma

Presurgical downstaging of vena caval tumor thrombus in advanced clear cell renal cell carcinoma using temsirolimus

(2012) Futoshi Sano et al.   INTERNATIONAL JOURNAL OF UROLOGY

Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma

(2011) Yoshihiko Tomita et al.   EUROPEAN JOURNAL OF CANCER

The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus

(2011) Nicholas G. Cost et al.   EUROPEAN UROLOGY

Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma

(2011) Brian F. Chapin et al.   EUROPEAN UROLOGY

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

(2011) Brian I Rini et al.   LANCET

Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non–Clear Cell Renal Cell Carcinoma

(2010) Oscar Rodríguez Faba et al.   EUROPEAN UROLOGY

Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma

(2010) E. Jason Abel et al.   EUROPEAN UROLOGY

Complete Histologic Remission after Sunitinib Neoadjuvant Therapy in T3b Renal Cell Carcinoma

(2009) Grégoire Robert et al.   EUROPEAN UROLOGY

Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi

(2007) Pierre I. Karakiewicz et al.   EUROPEAN UROLOGY